Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo by unknown
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Macrophage (M¢) adhesion plays an important role in a variety of processes
including phagocytosis, inflammation, immunity, and atherosclerosis. Selective
interactions with other cells and with extracellular matrix depend on specific
plasma membrane receptors, for example, for Fc and complement, fibronectin
and laminin (1). Unique adhesion and spreading of MO on artificial substrata
such as glass or plastic often form the basis of cell isolation, but the surface
molecules involved in these immunologically nonspecific interactions have not
been identified . In early morphologic studies, Rabinovitch (2) described a role
for Mgt+ in spreading of murine peritoneal Mo on glass, and Bianco et al. (3)
and Gotze et al. (4) implicated proteolytic enzymes generated by activation of
the coagulation and complement cascades as modulators of human monocyte
spreading in vitro. However, the relationship between adhesion and spreading
and the relevance of these in vitro phenomena to adhesive interactions in vivo,
such as endothelial cell binding and migration into tissues, remain obscure.
Some structural insights have recently been gained into molecules responsible
for the recruitment of myelomonocytic cells to inflammatory sites. Human
patients lacking the leukocyte function-associated antigen (LFA)' family of sur-
face receptors present with recurrent infection characterized by the failure of
circulating myelomonocytic cells to adhere to endothelium and to leave the
vascular compartment for tissue spaces (5), adiseaseknownas leukocyteadhesion
deficiency. The LFA family of noncovalently linked heterodimers consists of
LFA-1, p150/95, and the Mac-1 cell surface receptor for the complement
cleavage product iC3b, the type 3 complement receptor (CR3) (6). All three
proteins share a common j3chain of95 kD while having specific a chains of 150-
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170 kD. The recent cloning of the Q chain (7) has revealed an unusual repeated
cysteine-rich motif in the extracellular domain of the molecule and considerable
homology to the Integrin family, which includes fibroblast and platelet surface
receptors for fibronectin and other adhesive proteins. Myelomonocytic cells,
especially polymorphonuclear leukocytes (PMN) isolated from patients with
leukocyte adhesion deficiency also display defective adhesion to various substrata
in vitro (8), but since all three members of the LFA family are absent at the cell
surface, it is not clear which component is normally responsible for particular
adhesive functions, nor has the role of these glycoproteins in MO adhesion been
adequately defined.
In this study we describe the characteristics of adhesion of murine peritoneal
M¢ and PMN in vitro and report the isolation of an anti-M¢ mAb that prevents
Mg"-dependent adhesion of Mo to bacteriologic plastic. This mAb, which is
directed against an epitope on CR3 that is distinct from the iC3b binding site,
inhibits myelomonocytic cell recruitment into the peritoneal cavity after injection
in vivo. We have therefore mimicked aspects of the leukocyte adhesion deficiency
in the mouse with a reagent restricted to only one member of the LFA family
and provide a strategy to isolate new potent inhibitors of cell adhesion acting in




Murine elicited macrophages (TPM) and PMN were harvested from the peri-
toneal cavity by lavage 4 and 1 d, respectively, after the intraperitoneal injection of 1 ml
Brewer's complete thioglycollate broth. Cytospin preparations stained with Giemsa re-
vealed that -80% of the 4-d exudate (3 X 10 cells on average) were MO and 795% of
the 1-d exudate (4 X 10° cells) were PMN . Bone marrow cells, ^-45% PMN, were obtained
by flushing the femoral cavity with PBS. Bacille Calmette-Guerin (BCG)-activated and
resident peritoneal Mo and Kupffer cells were isolated as described (9).
Animals.
￿
Mice (C57/BL or Pathology Oxford, PO), of either sex, were bred at the Sir
William Dunn School of Pathology. AO rats (specific pathogen-free) were from the MRC
Cellular Immunology Unit in our department.
Adhesion Assays.
￿
Cells were suspended in Iscove's modification of Dulbecco's Medium
with 20% FCS and plated at a density of 105 cells/well in 96-well plates that were either
flat-bottomed bacteriologic plastic (BP) (Flow Laboratories, Rickmansworth, United King-
dom) or tissue culture-treated plastic (TCP) (Sterilin, Ashford, United Kingdom). After
incubation for 30 min at 37 °C, plates were washed three times in PBS and adherent cells
were fixed with methanol. After staining with 10% Giemsa solution for 10 min, plates
were washed in tap water, dried, and the retained dye was solubilized in methanol. Stain
was quantified by measuring absorbance at 460 nm in an automatic plate reader (Dynatech
Laboratories, Inc., Alexandria, VA). This assay was linear between 5 X 10s and 105
adherent cells/well. In antibody inhibition experiments, hybridoma-conditioned media
were added to microtiter plates and cooled to 4°C before addition of cells in the same
medium . After preincubation at 4°C for 30 min, neither antibody-treated nor control
cells had adhered and the plates were then warmed to 37 °C for 30 min before washing
and processing. In detachment assays, 105 MO were plated in serum containing medium
and allowed to adhere for 60 min at 37° C. After washing to remove nonadherent cells,
antibody was added in medium and cellsincubated at 37'C for 30 min. Thereafter, plates
were washed and processed as above and the percentage of detached cells was calculated.
The effects of various inhibitors on adhesion were studied by preincubating cells in one
or more of 5 uM cytochalasin B (CB), 10 ug/ml colcemid, or 5 mM 2-deoxyglucose for
30 min at 4°C before performing the adhesion assay in medium with 10% FCS as
described above. Experiments assessing the cation requirements of adhesion were carriedROSEN AND GORDON
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out in Iscove's medium and 10% FCS with either 5 mM EDTA or 5 mM EGTA to restrict
Ca" and Mg", or Ca' alone. The absolute cation requirements were determined by
performing adhesion assays in Ca"- and Mgt+-free HBSS, with 10% FCS dialyzed to
remove divalent cations and defined quantities of added CaC12 or MgC12. The effect of
surface proteolysis on adhesion was assessed by treating cells in suspension with 0.5 mg/ml
Pronase (Boehringer Mannheim Biochemicals, Lewes, United Kingdom) or 0 .1 mg/ml
crystalline trypsin in Iscove's medium without added protein for 30 min at 37°C. After
washing the cells in 10% FCS, they were plated in serum-containing medium on the
appropriate substratum and assayed in the standard adhesion assay.
Antibody Production.
￿
mAb 5C6 was the product of a fusion between spleen cells from
an AO rat, immunized four times with TPM, and the Y3 rat myeloma line. The fusion
was performed as described by Galfre et al. (10). Hybridoma supernatants were screened
for inhibition of attachment and for detachment of TPM . One positive culture out of
1,056wells was isolated and cloned twice by limiting dilution. Antibody was purified from
ascites by sodium sulphate precipitation, anion-exchange chromatography on DEAE-
Sephacel (Pharmacia Fine Chemicals, Hounslow, United Kingdom) and gel filtration
chromatography on S-300 Sephadex (Pharmacia Fine Chemicals). Purity was assessed by
SDS-PAGE in 10% acrylamide gels using the buffer system of Wyckoff et al. (11) and
staining with Coomassie Blue. The IgG was free of any other protein bands when run
either reduced or nonreduced. F(ab')2 fragments were prepared by pepsin digestion of
IgG at pH 4.0 in 0.1 M acetate after Rousseaux et al. (12) and purified by gel filtration
chromatography. Fab fragments were produced by papain digestion of IgG in 75 mM
sodium phosphate, pH 7 .0/75 mM NaCl and purified by anion-exchange chromatography
on DEAE-Sephacel. 5C6 is a rat IgG2b as typed by Ouchterlony gel diffusion using
antisera directed against rat IgG subclasses supplied by Dr. H. Bazin (Catholic University,
Louvain, Belgium). 5C6 was fluoresceinated by the method of Mason (13).
Labeling, Immunoprecipitation, and SDS-PAGE.
￿
4-d TPM were plated at 10' cells/10-
cm tissue culture dish and cultivated overnight in methionine-free medium with 200 ,uCi
[35S]methionine. After a chase incubation with unlabeled methionine, the cells were
washed in PBS and lysed in I % vol/vol Triton X-100 in PBS, 10 mM EDTA, 3 mM
PMSF and 3 mM iodoacetamide, After preclearing the lysate with protein A-Sepharose,
mAb in detergent was added for 60 min at VC. C. Thereafter, the mAb-antigen complex
was precipitated with rabbit IgG anti-rat IgG-protein A-Sepharose. The beads were
washed by standard methods and boiled in sample buffer containing 2% SDS. The eluates
were analyzed by electrophoresis on 10% polyacrylamide gels and autoradiography.
Control preparations contained an mAb to determinants not found in mouse MO. In
peptide mapping experiments, 5C6 and M1/70 immunoprecipitates on protein A-Seph-
arose beads were digested for varying times at 37 °C with 100 kg/ml crystalline trypsin.
The reaction was stopped by boiling the beads in SDS sample buffer and the resultant
cleavage patterns were analyzed by SDS-PAGE.
Preparation of Derivatized Substrata.
￿
Fibronectin-coated surfaces were prepared by
coating tissue-culture plastic surfaces with gelatin followed by fresh mouse serum for 1 h
at room temperature. The wells were then extensively washed with PBS. Poly-L-lysine-
coated, glutaraldehyde-activated surfaces were derivatized with DNP/BSA anti-DNP
immune complexes as described (14).
Chemotaxis Assay.
￿
The directional migration of myelomonocytic cells in response to
the chemotactic tripeptide FMLP was assayed under agarose as described (15).
Recruitment Assays.
￿
PO mice were injected intravenously with PBS, 5C6 IgG, 5C6
F(ab')2, or the anti-L3T4 subclass-matched (IgG2b) YTA mAb, 4 h before injection of 1
ml thioglycollate broth intraperitoneally. All antibody injections were 0.5 mg unless stated
otherwise. At 18 or 96 h after the first injection, mice were killed and peritoneal exudate
cells, blood, livers, spleens and bone marrows were removed. Total-and differential counts
of exudate cells, bone marrow ceps, and blood leukocytes (after sedimentation of eryth-
rocytes with 1 % Dextran T500) were obtained using May-Grunwald-Giemsa stain. Inhi-
bition of recruitment by mAb was calculated as: Inhibition = [(total exudate cells) -
(resident cells in antibody-treated mice)]/[recruited cells from control mice]. Cells were1688
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then tested for adhesion to BP or TCP. Livers and spleens were examined histologically
as follows. In some experiments tissues were fixed in glutaraldehyde and stained with
haematoxylin and eosin. In experiments where FITC-5C6 had been injected in vivo,
organs were examined for the presence of mAb by direct immunofluorescence of frozen
sections (5 gm) embedded in Tissuetek (Miles Laboratories Inc., Naperville, IL). Alter-
natively, animals were perfusion-fixed as described (16) and frozen sections oftissues were




Sheep erythrocytes (E) were opsonised with IgM antibody and iC3b
or C142 (17),or rabbit anti-sheepE IgG and used as a 5% vol/vol suspension for rosetting
at 4°C or phagocytosis at 37°C by adherent TPM (18). Binding was quantified by
counting the number of attached erythrocytes to 100 TPM by phase-contrast microscopy
after washing and glutaraldehyde fixation.
Microscopy.
￿
Fluorescence microscopy was performed using a Zeiss Axiophot epifluo-
rescence microscope. Scanning electron microscopy was performed as described (18).
Reagents.
￿
M1/70, a rat anti-CR3 mAb, was used either as IgG or hybridoma super-
natant from laboratory stocks. The cell line was the gift of Dr. T. Springer (Dept. of
Pathology, Harvard Medical School, Boston, MA). YTA mAb was a gift of Dr. H.
Waldmann (Dept. of Immunology, University of Cambridge, Cambridge, United King-
dom). Rabbit anti-E IgM (EA) and EA iC3b were provided by Dr. R. Sim (MRC
Immunochemistry, University of Oxford, Oxford, United Kingdom). Reagents were
obtained from the following sources: Iscove's medium (Flow Laboratories, Inc.); FCS
(Gibco Laboratories, Paisley, Scotland); Colcemid (Dr. E. P. Evans, Sir William Dunn
School of Pathology); Deoxyglucose, cytochalasin B, EDTA, and EGTA (Sigma Chemical
Co., Poole, United Kingdom); Protein A-Sepharose (Pharmacia Fine Chemicals).
Protein Assays.
￿
Protein concentrations of IgG were assayed according to Lowry et al.
(19) using BSA as the standard.
Results
Adhesion Assays. We characterized M(p and PMN adhesion in a variety of
simple, reproducible, short-term adhesion assays to develop a screening method
for mAbs directed against functional epitopes of phagocyte surface molecules.
Adherence of various primary murine MO to TCP or BP (polystyrene) was
examined because selective adherence of Mo to these substrata forms the basis
of their rapid purification from other blood cells and fibroblasts (20). All assays
were carried out in the presence of serum. The comparative adhesive qualities
of different cells to the plastic substrata are shown in Table I. The adhesion of
Mo and exudate PMN to BP was Mgt'-dependent, pronase-sensitive, and re-
quired elevated temperature as well as cytoskeletal stabilization for efficient
binding. Exposure of TPM to 0.5 mg/ml pronase at 37 °C for 30 min completely
abolished their ability to adhere to BP. This effect persisted for at least 6 h and
cells recovered fully by 24 h in culture. Resting PMN and tissue MO such as
Kupffer cells were unable to adhere to BP. Adhesion to BP required at least 100
,uM extracellular Mgt+ , and Ca2' alone was unable to substitute for this require-
ment. The adhesion of PMN (whether resting or exudate) to TCP had the same
qualities as M¢ adhesion to BP. All cell types tested adhered well to TCP and
showed varying degrees of spreading. As in BP adhesion, Mo adhesion to TCP
required elevated temperature and an intact cytoskeleton, but differed in being
resistant to proteolysis and was partially cation-independent.
The adherence of M¢ to BP appeared to be a useful means of identifying a
pronase-sensitive, cation-dependent surface component involved in cell adhesion.TABLE I
Adhesion ofCells In VitroAfter 30 Min at 37°C in 10% FBS. Absorbance ofGiemsa at 460




Results of quadruplicates in three separate experiments are expressed as the mean absorbance and
the mean tSD of adherent cell number calculated from an internal standard. ~10' myelomonocytic
cellswere plated/well.
We thus used this assay to screen for functional mAbs capable of, first, inhibiting
attachment ofTPM to BP and, second, detaching adherent TPM from BP.
mAb SC6 Inhibits Adhesion to BP and Detaches Adherent TPM.
￿
In each of two
consecutive fusions, one hybridoma secretinga mAbcapable ofinhibitingattach-
ment ofTPM to BP was isolated. Both identify the same antigen and this report
is confined to the first of these mAbs, designated 5C6. The effects ofmAb 5C6
on adhesion of TPM to bacterial and TCP are illustrated in phase micrographs
in Fig. 1 . Fig. 1A shows that untreated 4-d TPM adhered and spread on BP
after 30 min at 37°C in serum-containing medium. Preincubation ofthese cells
in 5C6 hybridoma supernatant for 30 min at 4°C before warming to 37°C to
allow adhesion, led to the complete abolition of TPM attachment to BP (Fig.
1B). While untreated TPM adhered and spread on TCP after 30 min at 37°C
(Fig. 1 C), cells preincubated with 5C6 showed unimpaired adhesion to TCP, but
did not spread at all (Fig. 1 D). The adhesion of untreated TPM to glass was
similar to that observed on TCP. Control TPM adherent to glass as shown in
the scanning electron micrograph in Fig. 2A, were flat and well spread. After
these cells had been preincubated in 5C6 mAb (Fig. 2B), the cells adhered via a
relatively small, snail-like foot process while the bulk of the plasma membrane
remained in a highly ruffled dome over the cell body. Adhesion of Mo to glass







x 10"' x 10-'
Resident peritoneal MO 0.174 96 :t 4 0.135 74 t 3
Thioglycollate PMO 0.189 104 t 5 0.147 81 t 5
Kupffercells 0.181 99 ± 3 0.002 1 t 3
Bone marrow PMN 0.180 99 ± 3 0.008 4 t 3
Exudate PMN 0.186 102t 4 0.151 83 t 5
Cation requirement (TPM)
Mga* present (no Ca21) 0.161 88 t 4 0.118 65 t 3
Cas* present (no Mgt+) 0.104 57 t 5 0.004 2 t 2
Neither present 0.104 57 ± 5 0.004 2 t 2
Protease sensitivity (TPM)
Trypsin 0.178 98 t 3 0.152 84 t 4
Pronase 0.182 100 ± 2 0.005 3 t 2
Metabolicand cytoskeletal factors (TPM)
Controls (37°C, no in- 0.152 84 t 4 0.135 74 t 3
hibitors)
Temperature <4°C 0.008 4 t 3 0.004 2 t 2
Cytochalasin B 5 AM 0.072 40 ± 3 0.058 32 ± 3
Colcemid (10 wg/ml) 0.063 35 t 5 0.049 27 t 4
Cytochalasin B + col- 0.006 3 t 2 0.002 1 t 2
cemid





mAb 5C6 inhibited adhesion of TPM to BP and spreading ofTPM on TCP .
TPM were preincubated in medium alone (A and C) or 5C6 hybridoma supernatant (B and
D) and 106 TPM were plated in 1 ml of medium with 10% FCS on a 35-mm petri (A and B)
or tissue culture dish (C and D) and allowed to adhere for 30 min at 37°C. After washing
three times in PBS, adherent cells were fixed in 0.5% glutaraldehyde and examined by phase-
contrast microscopy . 5C6-treated cells failed to adhere to BP (B)and failed to spread on TCP
(D), while control cellsadheredand spread on both BP (A)and TCP (C) .FIGURE 2 .
￿
Scanning electron micrographs of control and 5C6-treated TPM adherent to
glass . Treatmentand preparation as in Fig. 1 . After fixation in glutaraldehyde and cacodylate
buffer, preparations were critical point-driedandshadowed with gold. Control preparations
(A) were well spread while 5C6-treated preparations (B) adhered through a snail-like foot
process and remained rounded with plasma membrane ruffles over the cell body .
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FIGURE 3. Quantitative adhesion as-
says after preincubation of cells in me-
dium alone (C), 5C6, or M1/70 mAb .
105TPM or marrow PMN (BM) were
plated per well in 96-well plates on BP
TCP. Results show the mean t SD of
quadruplicates in three separate experi-
ments after incubation for 30 min at
37°C, washing, and Giemsa staining.
Cell number was calculated from an in-
ternal standard of 10 5 adherent
cells/well .
TABLE 11
A Comparison of the Functional Characteristics of5C6 mAb Intact IgG, F(ab')2, andFab
Fragments] andM1/70IgG
5C6 IgG, F(ab')2and Fabwere used at 1, 10, and 100 t+g/ml respectively whileM1/70 wasused at
10 kg/ml . Rosettingwas quantified as described in Materials andMethods. Results reflect themean
±SD of at least three separate experiments.
*TPM were digested in suspension (30 min, 37°C) with 0.5 mg/ml pronase, fixed in 0.25%
glutaraldehyde, quenched in FCS, and 106 cells were assayed in quadruplicate by trace indirect
binding assay (two experiments) . Untreated cellsbound 3,903 t 47 cpm of second antibody after
binding of 5C6 and 3,336 t 51 cpm after pronase digestion. Untreated cells bound 3,292 ± 35
cpm using M1/70 as first antibody and only 866 t 12 cpm after pronase treatment . The Mo-
specific F4/80 antigen known to be pronase-sensitive was abolished by this treatment.
and TCP had two phases, mAb 5C6-resistant adherence followed by mAb 5C6-
sensitive spreading.
Fig . 3 and Table II summarize quantitative assays of adhesion in the presence
or absence ofmAb and show that 5C6 IgG at 0.5 jug/ml inhibited attachment of
TPM to BP by 92 ± I%, while untreated cells or cells treated with saturating
concentrations of the anti-CR3 mAb M1/70, used for comparison, displayed
unaltered adhesive capacities. The increased adherence of MI/70-treated cells
as compared with untreated cells reflected aggregation of cells by this antibody
and adhesion of these clusters . In addition to its effects on Mo adhesion, 5C6
also abolished the adhesion ofPMN to TCP, which was unimpaired in control
or M1/70-treated PMN. While M1/70 treatment led to aggregation of myelo-
monocytic cells in suspension, 5C6-treated PMN or Mo remained discrete .
5C6 IgG 5C6 F(ab') 2 5C6 Fab M1/70 IgG
Inhibition ofTPM adhesion to BP 92 ± 1 51 t 3% 0% -22%
Detachment of adherent TPM (BP) 65 t 4% 8t3% 5t2% 6t3%
Inhibition of EiC3b rosetting >95% >95% 0% >95%
Pronase* resistance of epitope 85 t 1 ND ND 26 t 1%ROSEN AND GORDON
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FIGURE 4. Detachment by mAb 5C6
of TPM adherent to BP, or of bone
marrow PMN (BM) adherent to TCP.
Assay as described in Materials and
Methods . Medium alone (C) or M1/70
supernatant (M1l70) failed to detach
either TPM from BP or BM from TCP .
Results expressed as mean t SD (tripli-
cates in two separate experiments) .
The CSAT antigen or fibronectin receptor of avian fibroblasts was identified
by the ability of antibody to detach cells adherent to a fibronectin-coated
substratum (21) . After this precedent, we examined the ability of5C6 to detach
TPM from BP or bone marrow PMN from TCP. After allowing cells to attach
and adhere for 60 min at 37°C, plates were washed and medium containing
saturating concentrations (5 ,ug/ml) of5C6 orM1/70 or no antibody was added .
Within 5 min at 37 °C, spread cells treated with 5C6 had become rounded while
M1/70-treated and control cells were unaltered . By 30 min at 37°C (Fig. 4),
65% of 5C6-treatedTPM and >85% of 5C6-treated PMN were detached . This
differed substantially from the 3% of MI/70-treated TPM or PMN detached in
the same period . Detachment by lower concentrations of mAb (0.05 kg/ml) was
slower, with 30 min needed for rounding of adherent cells and 90 min for
detachment . The attachment ofTPM to defined substrata such as fibronectin or
immune complexes was unaffected by 5C6 mAb (not shown) .
mAb5C6 Binds to CR3and Inhibits iC3b Binding.
￿
The antigen recognized by
5C6 was characterized by the cell binding profile of the mAb and the molecular
species identified by immunoprecipitation . Indirect bindingRIAs with fixed cells
and direct immunofluorescence studies of live cells revealed that 5C6 bound to
a methanol- and glutaraldehyde-stable epitope on TPM, RPM, BCG-activated
M0, and PMN that was absent from the surface of Kupffer cells (as gauged by
immunoperoxidase staining) and from resting or BCG-activated lymphocytes .
Immunoprecipitation of 5C6 antigen from [s5S]methionine-labeled TPM re-
vealed a heterodimer of 165 kD and 95 kD which comigrated with CR3 as
precipitated by MI/70 (Fig. 5) . Further proof of the identity of these molecules
was that the 165-kD chain precipitated by 5C6 peptide mapped identically to the
a chain ofCR3 after limited tryptic cleavage (not shown) . In addition, like intact
M1/70, both 5C6 IgG and its F(ab')2 fragment, but not Fab, inhibited rosetting
ofEAiC3b toTPM (Table II) whereas no inhibition of rosetting of EAC142 or
EIgG (FcR) was seen (not shown) . Maximal inhibition of EAiC3b rosetting was
obtained with 0.35 kg/ml of 5C6 IgG .





FIGURE 5 . SDS-PAGE (10% gel) and autoradiography of ['SS]-
methionine-labeled immunoprecipitate of cultured TPM . Control
preparation was precipitated with the rat anti-guinea pig PMN
mAb 1A10.4, while both M1/70 and 5C6 precipitated a heterodi-
mer of 165 and 95 kD that comigrated .
5C6 and M1/70 in their ability to inhibit adhesion of TPM to BP led us to
explore the possibility that the two antibodies identify distinct epitopes on the
CR3 molecule . We therefore compared the sensitivity of the binding of these
antibodies to proteolytic digestion of the TPM cell surface . Digestion of the cell
surface with pronase (0.5 mg/ml for 30 min at 37°C) destroyed most of the
M1/70 binding sites and abolished the M¢-specific F4/80 epitope, whereas the
5C6 sites were more resistant to proteolysis (Table 11) . The 5C6 antigen, like
that of M1/70, is probably an a chain epitope, as it was restricted to myelomon-
ocytic cells and was absent on lymphocytes that are rich in LFA-1, which shares
a common (3 chain with CR3. The 5C6-epitope might require a chain together
with the common a chain since after dissociation of chains by pH 11.5 in solution,
5C6 failed to precipitate any antigen . The 5C6 epitope was also dissociated from
the adhesive domain of CR3 because pronase digestion abolished adhesion of
TPM to BP while binding of 5C6 was largely intact (Table 1) .
Optimal Inhibition ofAdhesion Requires IntactIgG .
￿
We examined the ability of
defined Ig fragments to alter Mo adhesion to BP in vitro . Intact 5C6 IgG
inhibited adhesion ofTPM by 92% compared with untreated cells (Table I1) .
The F(ab')2 fragment of5C6 inhibited ^-50% adhesion despite binding compar-
ably to the intact IgG in indirect binding assays . The Fab fragment also bound
well showing 50% saturation at 0.1 lAg/ml of protein, but did not inhibitTPM
adhesion . Interestingly, in experiments usingpurified 5C6 IgG at concentrations
of0.05 mg/ml where monovalent binding becomes significant, functional activity
of the IgG diminished in a prozone-like phenomenon . It was clear that divalent
binding was thus a prerequisite but alone was insufficient to inhibit adhesion .
Only the intact 5C6 IgG was able to reverse adhesion, but detachment under
these conditions was partial .
The Effect ofmAb 5C6 on Recruitment ofMyelomonocytic Cells to an Inflammatory
Site In Vivo . We next examined the possible role ofCR3 in the recruitment of





Injection of5C6 IgG In Vivo Inhibited Recruitment ofMyelomonocytic Cells to a Peritoneal
Exudate: The Effect of Treatments on 18-h Peritoneal Exudates and Blood Leukocytes
The treatmentpreceded intraperitonealthioglycollate injection by 4 h in all cases. Controls, animals
not exposed to thioglycollate broth, with or without 5C6 IgGpretreatment, yielded 5-6 X 106cells,
35% M, 65% L. Blood andbone marrow cell counts were also unchangedfrom controls.
TABLE IV
The Effects of 5C6 IgG Treatmenton 4-d Peritoneal Exudates and Blood Leukocytes
purified 5C6 IgG was followed 4 h later by an intraperitoneal challenge ofsterile
thioglycollate broth. A total of 22 5C6 IgG-injected mice and 20 control mice
were examined in this series of experiments (Tables III and IV).
In control animals, which received nothing or PBS alone, recruitment of cells
to the peritoneal cavity 18 h after thioglycollate injection was unimpaired. Cell
yields were enhanced three- to fourfold over untreated controls and consisted
predominantly of PMN and Mo. By 4 d the recruited peritoneal cell yields had
dropped by 25%, with a higher proportion of Mo and fewer PMN . In two mice
injected intravenously with 0 .5 mg of YTA, an isotype-matched mAb directed
against CM antigen, 22 X 106 peritoneal cells were recovered at 18 h compared
with 26 X 106 cells recovered from PBS injected animals in the same experiment,
showing a small diminution of recruitment. In striking contrast, peritoneal
recruitment in the 5C6 IgG-injected animals was reduced by 84 ± 3% at 18 h,
whereas peritoneal yields in animals that received the mAb, but no thioglycollate
broth, were unaffected. Inhibition of recruitment persisted for at least 4 d in
5C6 IgG-treated animals. From differential counts we calculated that 3.1 X 106










n X 10-6 X 10-6
PBS i.v. or 16 36 t 4 54P 40M 6L 16 t0.2 80P 12M 8L
nothing
0.5 mg i.v. 18 9.0 f 2 35P 51M 14L 17 t0.2 77P 13M IOL
5C6 IgG
0.5 mg i.v. 2 26 71P 29M 15 72P 13M 15L
5C6 F(ab')s
0.5 mg i.v. 2 22 65P 33M 2L 14 75P IOM 15L
YTA IgG
Peritoneal exudate Blood leukocytes
Treatment Mice Number of Number
cells Differential of Differential
cells/ml
n X 10-6 X 10-6
PBS i.v. 4 27 ± 4 P25 M66 L9 9.1 55P 12M 33L




in controls and 3.5 X 106 Mo after 4 d, compared with 1 .8 X 107 in controls.
The ability of 5C6-intact IgG to inhibit recruitment of myelomonocytic cells
correlated with its inhibition ofadhesion in vitro, whereas the F(ab')2 fragments,
which showed only partial inhibition of adhesion in vitro, failed to impair
recruitment in vivo. The inhibition of recruitment by 5C6 IgG was dose-
dependent: 0.5 mg i.v. IgGwas thesmallest dose ofIgGable to inhibit peritoneal
recruitment >80% at 18 h and inhibition of recruitment by 0.1, 0.2, and 0.35
mg was 40, 51, and 68%, respectively (one experiment, two mice per data point).
Peritoneal cells recovered after intravenous treatment with mAb adhered well
to both BP and TCP in vitro, suggesting that their exposure to 5C6 had been
subsaturating. Experiments in which 5C6 mAb was injected directly intraperi-
toneally, resulted in binding of antibody to all peritoneal MO which, when
harvested, had lost their ability to adhere to BP or spread on TCP, like M¢
treated with mAb in vitro.
The blood, bone marrow, liver, and spleen of control and mAb-treated mice
were examined to identify its site ofaction. There was no difference in number
or differential counts offemoral marrow cells between control and 5C6-treated
mice (six experiments, not shown). Marrow plugs were lightly fixed in para-
formaldehyde, embedded, and stained by the immunoperoxidase method after
frozen section to detect mAb that had bound in vivo. Marrows from 5C6-treated
mice showed heavy labeling of most mature myelomonocytic cells (not shown).
Blast cells, lymphocytes, and resident bone marrow Mo remained unlabeled, as
expected. There was no evidence ofcell death.
Table III shows the analysis ofblood leukocytes in control and experimental
animals. Thioglycollate broth elicited a PMN leukocytosis at 18 h, which was
similar in antibody-treated and untreated mice. In mice that had not been
exposed to thioglycollate, with or without 5C6 IgG pretreatment, there were 7-
10 X 106 cells/ml, 60-67% PMN. These data showed that the egress of myelo-
monocytic cells from marrow into blood had not been impaired. Furthermore,
blood leukocytes in both control and 5C6 IgG-treated mice were not aggregated.
Blood PMN from control animals adhered well to BP and TCP in vitro, whereas
blood leukocytes from 5C6-IgG-treated mice failed to adhere to either substra-
tum (not shown).
Histological analysis of sections of liver and spleen showed no evidence of
leukocyte aggregation, cell death, or removal by phagocytosis. Particular atten-
tion was paid to the examination of liver sinusoids and the splenic red pulp and
no differences were discerned between control and mAb-treated animals. These
observations made it unlikely that excessive PMN margination or phagocytic
clearance was responsible for the failure to recruit myelomonocytic cells to the
peritoneal cavity.
The observed inhibition ofrecruitmentby antibody could be due to inhibition
ofadhesion ofcirculatingcells to endothelium and/or failure ofmarginated cells
to undergo directional migration into the tissue spaces. We therefore examined
the ability of bone marrow leukocytes from 5C6-treated and control mice to
undergo chemotaxis in response to FMLP in an under-agaroseassay (six animals,
three experiments). There was no difference in the distance migrated by bone
marrow PMN from 5C6 IgG-treated or control mice (not shown), indicatingROSEN AND GORDON
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that the mAb treatment in vivo had not impaired the ability of leukocytes to
respond to a defined chemotactic stimulus.
Discussion
Our main conclusion is that the CR3 molecule contributes to a particular type
ofadhesion of myelomonocytic cells in vitro and in vivo. Our strategy of screening
for mAbs that could inhibit or reverse the adhesion of TPM to BP yielded an
inhibitor of inflammatory cell recruitment in vivo, most likely by interfering with
adhesion to endothelium. In the light of findings in the leukocyte adhesion
deficiency syndrome, it is perhaps not surprising that the 5C6 mAb was directed
against the CR3 molecule, to an epitope distinct from the iC3b binding site. Our
studies show that the CR3 is necessary for certain adhesive and migratory
functions of leukocytes and suggest a strategy to isolate novel inhibitors of
inflammation that interfere with recruitment of myelomonocytic cells.
Adhesion of Myelomonocytic Cells In Vitro.
￿
The differences between BP and
TCP are not well documented, but it is clearthat leukocytes are unusual in their
ability to adhere to both substrata, in the presence of serum. Our studies with
various inhibitors have defined at least two modes of adhesion, firstly CR3-
dependent, pronase-sensitive adhesion of myelomonocytic cells to BP. This
depends on Mg2+, like some other LFA-adhesive interactions (22) and is readily
reversible by chelation or selected mAb such as 5C6. The requirement of Mgt+
for CR3-dependent adhesion correlates with the cation requirements for the
rosetting of complement-opsonised erythrocytes to murine myelomonocytic cells
(23), but differs from human monocyte CR3, which requires both calcium and
magnesium for binding and phagocytosis (24). This adhesive mechanism provides
a useful method for isolation of certain MO populations. Only M¢ that express
surface CR3 can bind to BP, unlike Kupffer cells (9) and certain tissue MO (25),
suggesting that other adhesive molecules on M¢ cannot replace this particular
function. Immature PMN do not adhere to BP under these conditions, but this
deficiency can be overcome by inflammatory stimuli, which are known to increase
surface expression of CR3 in PMN by exocytosis (26).
Secondly, there is CR-independent, pronase-resistant, and Mo-specific adhe-
sion to TCP or glass. Studies with mAb 5C6 show that the CR3 can contribute
to spreading of elicited Mo on glass, but adhesion depends on an undefined
mechanism, which at present can only be reversed by local anaesthetics (2).
Further studies, perhaps with specific mAbs that inhibit this function, are needed
to establish whether this is due to a single or multiple Mo-adhesive molecule(s).
The relationship between Mo adhesion and spreading is complex, but specific
inhibitors such as 5C6 make it possible to dissect the contribution of the CR3
molecule to these processes. The mechanism of 5C6 IgG-mediated inhibition of
adhesion is unclear. Inhibition of CR3 adhesion by an antibody or antibody
fragment was not conferred by the ability of an antibody to prevent the binding
of iC3b to its receptor. This is evident from the failure of M1/70 and the 5C6
F(ab')2 adequately to inhibit adhesion while efficiently blocking iC3b binding.
The epitope recognized directly by 5C6 is also dissociated from both the adhesion
and iC3b binding sites of CR3 because the 5C6 Fab fragment bound excellently
in direct binding assays (not shown), and in fact, competed with the intact IgG1698
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while having no functional inhibition ofeither of those two functions. The 5C6
antigen, unlike adhesion function, was relatively resistant to pronase digestion,
again suggesting that this epitope is distinct from both adhesion and iC3b binding
domains. The requirement for divalent binding for functional inhibition by
antibody is consistent with a mechanism that involves steric hindrance. The
requirement for intact IgG to inhibit adhesion efficiently could be ascribed to
the following mechanisms: (a) the Fc gives added length to the intact molecule,
which is necessary for efficient steric hindrance; (b) the Fc portion might alter
the relative mobility of the two antigen binding sites, altering their functional
activity; and (c) the Fc might bind to the surface of the same cell as the antigen
binding site (? via FcR), and in some indirect way further impair adhesion. In
any event, further experiments are needed to elucidate the role of the Fc
fragment ofintact 5C6 IgG.
The reversible nature of CR3-mediated adhesion is shown in the detachment
assays. Such detachment could result from limiting available receptor numbers
below a threshold critical for adhesion, by competing with substratum for
receptor binding or by uncoupling receptors from cytoskeleton . The inhibitory
effect ofcytoskeletal inhibitors in the in vitro assay system highlights the role of
cytoskeleton in stabilizing CR3-mediated attachment.
Inhibition of Inflammatory Cell Recruitment In Vivo.
￿
Intravenous injection of
relatively small amounts of 5C6 mAb, 0.5 mg/animal, resulted in a profound
and relatively prolonged (>4 d) inhibition of recruitment of PMN (1 d) or Mo
(4 d) into a thioglycollate-challenged peritoneal cavity. The effect was highly
reproducible, antibody-specific, dose-dependent, and not observed with the
F(ab')2 fragment, a poor inhibitor ofadhesion in vitro. Further studiesconfirmed
that the 5C6 antibody bound to bone marrow and circulating PMN in vivo and
had nodetectable effect on leukocytosis oregress from bone marrow. Circulating
PMN tested after antibody treatment could not adhere in vitro, suggesting
functional activity ofantibody in vivo. The failure to recruit cells was not due to
cytotoxicity, opsonization and clearance by phagocytosis, or aggregation within
the circulation. Furthermore, treated PMN had unimpaired adhesion to other
substrata in vitro, such as fibronectin-coated surfaces (our unpublished observa-
tions) and were fully able to respond to chemotactic stimuli such as FMLP.
Taken together, these studies suggest that 5C6 impaired the interaction of
myelomonocytic cells with endothelium, but further studies are needed to
substantiate this hypothesis. Studies by others have implicated CR3 and LFA-1
molecules in leukocyte adhesion to endothelial cells in vitro (27). In an in vivo
study similar to ours, Arfors et al. (28) have shown that a murine mAb directed
against the CD18 complex, i.e., all members of the LFA family, inhibited both
neutrophil accumulation and plasma leakage in rabbits, presumably by impairing
interactions with the vascular endothelium. Our study now shows that an equally
striking inhibition can be achieved with an antibody directed to CR3 alone.
The cells obtained from the peritoneal cavity after thioglycollate broth injec-
tion under antibody cover showed no impaired adhesion. These could be either
original resident cells or recruited cells which had been insufficiently coated with
antibody, since injection of antibody intraperitoneally confirmed that direct
access to antibody in vivo inhibited subsequent adhesion in vitro.ROSEN AND GORDON
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These studies shed further light on the leukocyte adhesion deficiencysyndrome
in that it appears, at least in mice, that CR3 is necessary for migration of
myelomonocytic cells to an inflammatory focus. However, indirect effects of
CR3 ligation on expression of other members of the LFA family cannot be
entirely ruled out by the present experiments. The failure of M1/70, unlike
5C6, to inhibit adhesion or detach adherent cells in vitro supports the notion of
multiple functional domains on CR3 (29). The differences between 5C6 and
M1/70 underline the dissociation between binding to a particular antigen and
consequent functional effects. Strategies that are directly functional, as pursued
in this study, and in which in vitro observations can be correlated with effects in
vivo, are more likely to yield reagents that clarify complex physiologic processes,
regardless of the antigen to which they bind. The definition of discrete adhesion-
promoting domains on receptors such as CR3 can lead to development of novel,
specific inhibitors of inflammation that act at the point of myelomonocytic cell
exit from the circulation. Although the present studies implicate CR3 as a suitable
target for such therapeutic agents, other molecules may be involved in constitu-
tive entry of monocytes into tissues and enhanced recruitment of inflammatory
cells during T cell-dependent recruitment and activation of macrophages.
Summary
Macrophage interactions with extracellular matrix and other cells are impor-
tant in phagocytosis, inflammation, and immunity. To learn more about the
surface molecules involved in adhesion we compared the binding of murine
macrophages and polymorphonuclear leukocytes (PMN) with artificial substrate
in vitro. A distinctive type of adhesion of thioglycollate-elicited peritoneal mac-
rophages (TPM) to bacteriologic plastic (BP) was defined, which was pronase-
sensitive, Mg"-dependent, and required cytoskeletal stabilization. A rat mAb
designated 5C6 was isolated because it inhibited TPM attachment to BP, as well
as mediating detachment of TPM adherent to that substratum. In addition, it
inhibited the attachment of PMN to tissue culture plastic. This antiadhesive
property of 5C6 mAb required intact IgG; the F(ab')2 fragment was partially
effective and Fab was ineffective. 5C6 recognized the type 3 complement
receptor, inhibiting rosetting of EAC3bi to TPM and immunoprecipitating a
heterodimer of 160 and 95 kD that comigrated with the MI/70 immunoprecip-
itate. 5C6 recognized a pronase-stable epitope distinct from that of MI/70.
Other mAbs, including M1/70 (CR3) and 2AG2 (FcR), failed to have any
antiadhesive effect in vitro.
The inhibitory activity of 5C6 in short-term adhesion assays correlated with
its inhibition of recruitment of myelomonocytic cells to a thioglycollate-elicited
peritoneal exudate in vivo, afterintravenous injection o£ mAb. 5C6 IgG inhibited
recruitment of myelomonocytic cells by 84 ± 3% at 1 d compared with saline-
injected controls. The F(ab')2 fragment and a class-matched control IgG had
little effect. Recruitment of TPM at 4 d was also efficiently inhibited by 5C6
IgG. 5C6 IgG was not cytotoxic, had no effect on marrow egress, did not cause
increased phagocytic clearance of circulating neutrophils, and had no adverse
effect on chemotaxis in vitro. We show that CR3 alone of the LFA-family is
necessary for the recruitment of myelomonocytic cells to inflammatory stimuli1700
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such as thioglycollate broth. This strategy may be of general use in isolating
reagents that inhibit the adhesive function ofCR3 and provides a novel approach
to antiinflammatory therapy.
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